ReWalk Robotics Announces 2017 Focus and Operating Initiatives
“In the years since ReWalk received its
ReWalk will redouble its efforts in the New Year on reimbursement policies with insurance providers. This initiative stems from the
“We are hopeful the incoming administration will adhere to its promises of addressing systemic challenges in the VA, and set an example for the private sector to facilitate better health care benefit policies to provide access to all individuals who need a critical medical device,” Jasinski added.
In 2016, ReWalk announced a partnership with the
Included in the Company outlook, ReWalk has set a goal to reduce total operating expenses in 2017 by up to 30%, compared to 2016. These reductions will be achieved through the following three actions, each of which contribute approximately 1/3 of the targeted savings: the completion of specific projects focused on quality improvement initiatives and efforts to reduce overall product cost; a realignment of and reduction in staffing to match the Company’s 2017 business goals; and a reduction in other corporate spending. The Company will fund reimbursement efforts, clinical studies to expand data on the effectiveness of the Spinal Cord Injury products, field sales, service and training efforts for the ReWalk system and the commercialization pathway for the Stroke Softsuit program.
About ReWalk Robotics Ltd.
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. Our mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit http://www.rewalk.com.
ReWalk® is a registered trademark of
Contact:Lisa Wilson In-Site Communications, Inc. Investor Relations T: (212) 452-2793 E: lwilson@insitecony.com